Moneycontrol PRO
HomeNewsUk mhra

Uk Mhra

Jump to
  • Lupin gets UK MHRA nod for generic drug to manage COPD, asthma

    Lupin Healthcare (UK) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to market a generic version of Spiriva, the Mumbai-based drug firm said in a statement.

  • Indoco Remedies Goa plant gets UK MHRA nod, share up 7%

    The company, in an exchange to BSE said the plant-1 was inspected by MHRA in December last year.

  • Cipla shares gain 4% on UK MHRA nod for generic asthma drug

    Pharma company Cipla shares gained more than 4 percent intraday Friday after its flagship product Sereflo has received final approval from the UK health regulator.

  • Here is why pharma stocks were buzzing today

    CNBC-TV18's Varinder Bansal explains why pharma stocks were buzzing in trade today.

  • Wockhardt soars 5% after UK MHRA says Daman unit GMP complied

    Wockhardt shares rallied nearly 5 percent intraday Wednesday after the approval by UK health regulator to Daman-based facility continued.

  • Marksans up 19%, UK regulator allows manufacturing at Goa unit

    "UK MHRA issued a restricted good manufacturing practice certificate, allowing the company to continue manufacture and marketing of critical products for the UK markets," says Mumbai-based Marksans Pharma in its filing.

  • Wockhardt gains, Chikalthana unit gets UK MHRA certificate

    "The company has undergone recently an inspection at its L1-Chikalthana, Aurangabad manufacturing facility by UK MHRA and have received a communication confirming the closure of the inspection and issuance of an unrestricted GMP certificate," the pharma company said in its filing.

  • Wockhardt up 5%, USFDA gives clean chit to Chikalthana unit

    Shares of Wockhardt rallied 5.4 percent intraday Thursday after the US health regulator has not found any issues at Chikalthana plant.

  • US FDA initiates audit of Ipca's Indore SEZ; sales hit seen

    Surajit Pal of Prabhudas Lilladher feels the pharma company's US sales will take atleast 18 months to recover. He fears that if USFDA issue is raised then UK MHRA too may act.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347